Matches in SemOpenAlex for { <https://semopenalex.org/work/W2603984147> ?p ?o ?g. }
- W2603984147 endingPage "702" @default.
- W2603984147 startingPage "687" @default.
- W2603984147 abstract "Cell‐to‐cell transmission of protein aggregates is an emerging theme in neurodegenerative disease. Here, we analyze the dipeptide repeat (DPR) proteins that form neuronal inclusions in patients with hexanucleotide repeat expansion C9orf72 , the most common known cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Sense and antisense transcripts of the (G4C2)n repeat are translated by repeat‐associated non‐ATG (RAN) translation in all reading frames into five aggregating DPR proteins. We show that the hydrophobic DPR proteins poly‐GA, poly‐GP, and poly‐PA are transmitted between cells using co‐culture assays and cell extracts. Moreover, uptake or expression of poly‐GA induces nuclear RNA foci in (G4C2)80‐expressing cells and patient fibroblasts, suggesting an unexpected positive feedback loop. Exposure to recombinant poly‐GA and cerebellar extracts of C9orf72 patients increases repeat RNA levels and seeds aggregation of all DPR proteins in receiver cells expressing (G4C2)80. Treatment with anti‐GA antibodies inhibits intracellular poly‐GA aggregation and blocks the seeding activity of C9orf72 brain extracts. Poly‐GA‐directed immunotherapy may thus reduce DPR aggregation and disease progression in C9orf72 ALS/FTD.![][1] The pathogenic G4C2 repeat expansion upstream of C9orf72 is bidirectionally transcribed and translated into five aggregating dipeptide repeat proteins (DPRs). Analysis of cell‐to‐cell transmission of DPRs suggests that DPR‐directed antibodies may have therapeutic potential. [1]: /embed/graphic-1.gif" @default.
- W2603984147 created "2017-04-07" @default.
- W2603984147 creator A5002343259 @default.
- W2603984147 creator A5008731993 @default.
- W2603984147 creator A5014535603 @default.
- W2603984147 creator A5026005835 @default.
- W2603984147 creator A5026565602 @default.
- W2603984147 creator A5036062855 @default.
- W2603984147 creator A5037524614 @default.
- W2603984147 creator A5037719541 @default.
- W2603984147 creator A5049660794 @default.
- W2603984147 creator A5054997255 @default.
- W2603984147 creator A5055417854 @default.
- W2603984147 creator A5059133881 @default.
- W2603984147 creator A5062984476 @default.
- W2603984147 creator A5063004379 @default.
- W2603984147 creator A5063441147 @default.
- W2603984147 creator A5065084452 @default.
- W2603984147 creator A5066145730 @default.
- W2603984147 creator A5068968558 @default.
- W2603984147 creator A5081212472 @default.
- W2603984147 date "2017-03-28" @default.
- W2603984147 modified "2023-10-16" @default.
- W2603984147 title "Antibodies inhibit transmission and aggregation of <i>C9orf72</i> poly‐ <scp>GA</scp> dipeptide repeat proteins" @default.
- W2603984147 cites W1046033385 @default.
- W2603984147 cites W1533438796 @default.
- W2603984147 cites W1538003756 @default.
- W2603984147 cites W1878242548 @default.
- W2603984147 cites W1982797857 @default.
- W2603984147 cites W1984538960 @default.
- W2603984147 cites W1999242469 @default.
- W2603984147 cites W2007568107 @default.
- W2603984147 cites W2009191546 @default.
- W2603984147 cites W2013131112 @default.
- W2603984147 cites W2018852249 @default.
- W2603984147 cites W2022210358 @default.
- W2603984147 cites W2038735530 @default.
- W2603984147 cites W2051097977 @default.
- W2603984147 cites W2054542675 @default.
- W2603984147 cites W2059809766 @default.
- W2603984147 cites W2069171272 @default.
- W2603984147 cites W2071471772 @default.
- W2603984147 cites W2071921522 @default.
- W2603984147 cites W2073190029 @default.
- W2603984147 cites W2081966615 @default.
- W2603984147 cites W2092145129 @default.
- W2603984147 cites W2093650784 @default.
- W2603984147 cites W2106786486 @default.
- W2603984147 cites W2123193865 @default.
- W2603984147 cites W2137039075 @default.
- W2603984147 cites W2139264742 @default.
- W2603984147 cites W2150523249 @default.
- W2603984147 cites W2154945114 @default.
- W2603984147 cites W2166142331 @default.
- W2603984147 cites W2173406154 @default.
- W2603984147 cites W2215407066 @default.
- W2603984147 cites W2235199083 @default.
- W2603984147 cites W2328157766 @default.
- W2603984147 cites W2338545563 @default.
- W2603984147 cites W2340195634 @default.
- W2603984147 cites W2487926280 @default.
- W2603984147 cites W2510806376 @default.
- W2603984147 cites W2531459060 @default.
- W2603984147 cites W812488793 @default.
- W2603984147 doi "https://doi.org/10.15252/emmm.201607054" @default.
- W2603984147 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5412769" @default.
- W2603984147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28351931" @default.
- W2603984147 hasPublicationYear "2017" @default.
- W2603984147 type Work @default.
- W2603984147 sameAs 2603984147 @default.
- W2603984147 citedByCount "62" @default.
- W2603984147 countsByYear W26039841472017 @default.
- W2603984147 countsByYear W26039841472018 @default.
- W2603984147 countsByYear W26039841472019 @default.
- W2603984147 countsByYear W26039841472020 @default.
- W2603984147 countsByYear W26039841472021 @default.
- W2603984147 countsByYear W26039841472022 @default.
- W2603984147 countsByYear W26039841472023 @default.
- W2603984147 crossrefType "journal-article" @default.
- W2603984147 hasAuthorship W2603984147A5002343259 @default.
- W2603984147 hasAuthorship W2603984147A5008731993 @default.
- W2603984147 hasAuthorship W2603984147A5014535603 @default.
- W2603984147 hasAuthorship W2603984147A5026005835 @default.
- W2603984147 hasAuthorship W2603984147A5026565602 @default.
- W2603984147 hasAuthorship W2603984147A5036062855 @default.
- W2603984147 hasAuthorship W2603984147A5037524614 @default.
- W2603984147 hasAuthorship W2603984147A5037719541 @default.
- W2603984147 hasAuthorship W2603984147A5049660794 @default.
- W2603984147 hasAuthorship W2603984147A5054997255 @default.
- W2603984147 hasAuthorship W2603984147A5055417854 @default.
- W2603984147 hasAuthorship W2603984147A5059133881 @default.
- W2603984147 hasAuthorship W2603984147A5062984476 @default.
- W2603984147 hasAuthorship W2603984147A5063004379 @default.
- W2603984147 hasAuthorship W2603984147A5063441147 @default.
- W2603984147 hasAuthorship W2603984147A5065084452 @default.
- W2603984147 hasAuthorship W2603984147A5066145730 @default.
- W2603984147 hasAuthorship W2603984147A5068968558 @default.
- W2603984147 hasAuthorship W2603984147A5081212472 @default.
!["Cell‐to‐cell transmission of protein aggregates is an emerging theme in neurodegenerative disease. Here, we analyze the dipeptide repeat (DPR) proteins that form neuronal inclusions in patients with hexanucleotide repeat expansion C9orf72 , the most common known cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Sense and antisense transcripts of the (G4C2)n repeat are translated by repeat‐associated non‐ATG (RAN) translation in all reading frames into five aggregating DPR proteins. We show that the hydrophobic DPR proteins poly‐GA, poly‐GP, and poly‐PA are transmitted between cells using co‐culture assays and cell extracts. Moreover, uptake or expression of poly‐GA induces nuclear RNA foci in (G4C2)80‐expressing cells and patient fibroblasts, suggesting an unexpected positive feedback loop. Exposure to recombinant poly‐GA and cerebellar extracts of C9orf72 patients increases repeat RNA levels and seeds aggregation of all DPR proteins in receiver cells expressing (G4C2)80. Treatment with anti‐GA antibodies inhibits intracellular poly‐GA aggregation and blocks the seeding activity of C9orf72 brain extracts. Poly‐GA‐directed immunotherapy may thus reduce DPR aggregation and disease progression in C9orf72 ALS/FTD.![][1] The pathogenic G4C2 repeat expansion upstream of C9orf72 is bidirectionally transcribed and translated into five aggregating dipeptide repeat proteins (DPRs). Analysis of cell‐to‐cell transmission of DPRs suggests that DPR‐directed antibodies may have therapeutic potential. [1]: /embed/graphic-1.gif"](?object=%22Cell%E2%80%90to%E2%80%90cell%20transmission%20of%20protein%20aggregates%20is%20an%20emerging%20theme%20in%20neurodegenerative%20disease.%20Here%2C%20we%20analyze%20the%20dipeptide%20repeat%20(DPR)%20proteins%20that%20form%20neuronal%20inclusions%20in%20patients%20with%20hexanucleotide%20repeat%20expansion%20C9orf72%20%2C%20the%20most%20common%20known%20cause%20of%20amyotrophic%20lateral%20sclerosis%20(ALS)%20and%20frontotemporal%20lobar%20degeneration%20(FTLD).%20Sense%20and%20antisense%20transcripts%20of%20the%20(G4C2)n%20repeat%20are%20translated%20by%20repeat%E2%80%90associated%20non%E2%80%90ATG%20(RAN)%20translation%20in%20all%20reading%20frames%20into%20five%20aggregating%20DPR%20proteins.%20We%20show%20that%20the%20hydrophobic%20DPR%20proteins%20poly%E2%80%90GA%2C%20poly%E2%80%90GP%2C%20and%20poly%E2%80%90PA%20are%20transmitted%20between%20cells%20using%20co%E2%80%90culture%20assays%20and%20cell%20extracts.%20Moreover%2C%20uptake%20or%20expression%20of%20poly%E2%80%90GA%20induces%20nuclear%20RNA%20foci%20in%20(G4C2)80%E2%80%90expressing%20cells%20and%20patient%20fibroblasts%2C%20suggesting%20an%20unexpected%20positive%20feedback%20loop.%20Exposure%20to%20recombinant%20poly%E2%80%90GA%20and%20cerebellar%20extracts%20of%20C9orf72%20patients%20increases%20repeat%20RNA%20levels%20and%20seeds%20aggregation%20of%20all%20DPR%20proteins%20in%20receiver%20cells%20expressing%20(G4C2)80.%20Treatment%20with%20anti%E2%80%90GA%20antibodies%20inhibits%20intracellular%20poly%E2%80%90GA%20aggregation%20and%20blocks%20the%20seeding%20activity%20of%20C9orf72%20brain%20extracts.%20Poly%E2%80%90GA%E2%80%90directed%20immunotherapy%20may%20thus%20reduce%20DPR%20aggregation%20and%20disease%20progression%20in%20C9orf72%20ALS%2FFTD.!%5B%5D%5B1%5D%20The%20pathogenic%20G4C2%20repeat%20expansion%20upstream%20of%20C9orf72%20is%20bidirectionally%20transcribed%20and%20translated%20into%20five%20aggregating%20dipeptide%20repeat%20proteins%20(DPRs).%20Analysis%20of%20cell%E2%80%90to%E2%80%90cell%20transmission%20of%20DPRs%20suggests%20that%20DPR%E2%80%90directed%20antibodies%20may%20have%20therapeutic%20potential.%20%5B1%5D%3A%20%2Fembed%2Fgraphic-1.gif%22){kind=link}